Role of DNA methyltransferase 1 in pharyngeal cancer related to treatment resistance

Chih Cheng Chen, Wen Cheng Chen, Wen Hung Wang, Chang Hsien Lu, Paul Yang Lin, Kuan Der Lee, Miao Fen Chen

研究成果: 雜誌貢獻文章同行評審

11 引文 斯高帕斯(Scopus)


Background: The purpose of the present study was to highlight the role of DNA methyltransferase 1 (DNMT1) and its potential for improving treatment and informing prognosis for pharyngeal cancer. Methods: Human pharyngeal cancer cell lines FaDu and its derivative FaDu-C225-R were selected for cellular experiments. Furthermore, 95 pharyngeal cancer tissue specimens were analyzed by immunohistochemical staining. Results: DNMT1 was over-expressed in pharyngeal cancer specimens and cells with activated interleukin (IL)-6 signaling. When DNMT1 activity was blocked, accelerated tumor growth and treatment resistance were overcome as demonstrated by cell culture and animal experiments. The reduction in DNMT1 was associated with increased apoptosis, cell cycle arrest, and augmented irradiation-induced free radical levels and DNA damage. Furthermore, positive staining for DNMT1 in clinical cancer specimens was significantly linked to lower rates of response to treatments and shorter survival of patients with pharyngeal cancer. Conclusion: DNMT1 may be a significant clinical predictor and a potential treatment strategy against head and neck cancer.
頁(從 - 到)1132-1143
期刊Head and Neck
出版狀態已發佈 - 8月 2011

ASJC Scopus subject areas

  • 耳鼻咽喉科


深入研究「Role of DNA methyltransferase 1 in pharyngeal cancer related to treatment resistance」主題。共同形成了獨特的指紋。